152 related articles for article (PubMed ID: 30390725)
41. Cutaneous drug reactions in patients admitted to the dermatology unit at the University Hospital of the West Indies, Kingston, Jamaica.
East-Innis AD; Thompson DS
West Indian Med J; 2009 Jun; 58(3):227-30. PubMed ID: 20043529
[TBL] [Abstract][Full Text] [Related]
42. Human herpes virus reactivations and dynamic cytokine profiles in patients with cutaneous adverse drug reactions --a prospective comparative study.
Chen YC; Chiang HH; Cho YT; Chang CY; Chen KL; Yang CW; Lee YH; Chu CY
Allergy; 2015 May; 70(5):568-75. PubMed ID: 25727950
[TBL] [Abstract][Full Text] [Related]
43. Oxidative stress and leukocyte migration inhibition response in cutaneous adverse drug reactions.
Verma P; Bhattacharya SN; Banerjee BD; Khanna N
Indian J Dermatol Venereol Leprol; 2012; 78(5):664. PubMed ID: 22960836
[TBL] [Abstract][Full Text] [Related]
44. Severe cutaneous adverse drug reactions: a clinicoepidemiological study.
Sasidharanpillai S; Riyaz N; Khader A; Rajan U; Binitha MP; Sureshan DN
Indian J Dermatol; 2015; 60(1):102. PubMed ID: 25657416
[TBL] [Abstract][Full Text] [Related]
45. Saline Vehicle Increases the Ability of Drug Patch Test in Cutaneous Adverse Drug Reactions.
Thaiwat S; Prompongsa S
Dermatology; 2023; 239(2):241-247. PubMed ID: 36599331
[TBL] [Abstract][Full Text] [Related]
46. The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions.
Hassoun-Kheir N; Bergman R; Weltfriend S
Int J Dermatol; 2016 Nov; 55(11):1219-1224. PubMed ID: 27368159
[TBL] [Abstract][Full Text] [Related]
47. Clinical Profile and Comparison of Causality Assessment Tools in Cutaneous Adverse Drug Reactions.
Beniwal R; Gupta LK; Khare AK; Mittal A; Mehta S; Balai M
Indian Dermatol Online J; 2019; 10(1):27-33. PubMed ID: 30775295
[TBL] [Abstract][Full Text] [Related]
48. Antihypertensives in dermatology Part II - Cutaneous adverse reactions to antihypertensives.
Ranugha PSS; Betkerur JB
Indian J Dermatol Venereol Leprol; 2018; 84(2):137-147. PubMed ID: 29405133
[TBL] [Abstract][Full Text] [Related]
49. Approach to the Patient with a Suspected Cutaneous Adverse Drug Reaction.
Swanson L; Colven RM
Med Clin North Am; 2015 Nov; 99(6):1337-48. PubMed ID: 26476256
[TBL] [Abstract][Full Text] [Related]
50. A Retrospective Study of Drug Induced Cutaneous Adverse Reactions (CADR) in Patients Attending Tertiary Care Hospital.
Doshi K; Yegnanarayan R; Gokhale N
Curr Drug Saf; 2016 Jul; ():. PubMed ID: 27457767
[TBL] [Abstract][Full Text] [Related]
51. HLA-A*02:01:01/-B*35:01:01/-C*04:01:01 haplotype associated with lamotrigine-induced maculopapular exanthema in Mexican Mestizo patients.
Fricke-Galindo I; Martínez-Juárez IE; Monroy-Jaramillo N; Jung-Cook H; Falfán-Valencia R; Ortega-Vázquez A; Alonso-Vilatela ME; López-López M
Pharmacogenomics; 2014; 15(15):1881-91. PubMed ID: 25495410
[TBL] [Abstract][Full Text] [Related]
52. Cutaneous drug reactions in children: a multicentric study.
Dilek N; Özkol HU; Akbaş A; Kılınç F; Dilek AR; Saral Y; Metin A; Çalka Ö
Postepy Dermatol Alergol; 2014 Dec; 31(6):368-71. PubMed ID: 25610351
[TBL] [Abstract][Full Text] [Related]
53. Patch testing in non-immediate cutaneous adverse drug reactions: value of extemporaneous patch tests.
Assier H; Valeyrie-Allanore L; Gener G; Verlinde Carvalh M; Chosidow O; Wolkenstein P
Contact Dermatitis; 2017 Nov; 77(5):297-302. PubMed ID: 28730661
[TBL] [Abstract][Full Text] [Related]
54. Histopathological study of six types of adverse cutaneous drug reactions using granulysin expression.
Weinborn M; Barbaud A; Truchetet F; Beurey P; Germain L; Cribier B
Int J Dermatol; 2016 Nov; 55(11):1225-1233. PubMed ID: 27421110
[TBL] [Abstract][Full Text] [Related]
55. Cutaneous Adverse Drug Reactions (CADRs) to COVID19 Vaccines: A Case Series.
Purushottam M; Rangappa V; Betkerur JB; Kombettu AP; Shastry V
Indian Dermatol Online J; 2023; 14(3):383-387. PubMed ID: 37266107
[TBL] [Abstract][Full Text] [Related]
56. Epidemiological study of severe cutaneous adverse drug reactions in a city district of China.
Li LF; Ma C
Clin Exp Dermatol; 2006 Sep; 31(5):642-7. PubMed ID: 16901302
[TBL] [Abstract][Full Text] [Related]
57. Cutaneous adverse drug reactions to psychotropic drugs and their risk factors - a case-control study.
Greil W; Zhang X; Stassen H; Grohmann R; Bridler R; Hasler G; Toto S; Bleich S; Kasper S
Eur Neuropsychopharmacol; 2019 Jan; 29(1):111-121. PubMed ID: 30424913
[TBL] [Abstract][Full Text] [Related]
58. Clindamycin-induced Maculopapular Exanthema with Preferential Involvement of Striae Distensae: A Koebner phenomenon?
Monteagudo B; Cabanillas M; Iriarte P; Ramírez-Santos A; León-Muinos E; González-Vilas D; Suárez-Amor Ó
Acta Dermatovenerol Croat; 2018 Apr; 26(1):61-63. PubMed ID: 29782303
[TBL] [Abstract][Full Text] [Related]
59. Cutaneous adverse drug reactions in a hospital setting.
Rademaker M; Oakley A; Duffill MB
N Z Med J; 1995 May; 108(999):165-6. PubMed ID: 7753511
[TBL] [Abstract][Full Text] [Related]
60. Spectrum of pediatric dermatological emergencies at a tertiary care hospital in India: a descriptive study.
Mathias RC; Jayaseelan E; Augustine M
Int J Dermatol; 2013 Jan; 52(1):27-31. PubMed ID: 22471326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
